Recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC): What about second-line chemotherapy combining cetuximab and platinum-doublet after EXTREME protocol?

2017 ◽  
Vol 72 ◽  
pp. S113 ◽  
Author(s):  
O. Regnier-Gavier ◽  
P. Coliat ◽  
H. Carinato ◽  
M. Burgy ◽  
D. Exinger ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy ◽  
Platinum Doublet

Methotrexate, Vinblastine, Epidoxorubicin, and Bleomycin as Second-Line Chemotherapy for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

ORL ◽  
1994 ◽  
Vol 56 (5) ◽  
pp. 279-282 ◽  
Author(s):  
Vittorio Gebbia ◽  
Roberto Valenza ◽  
Antonio Testa ◽  
Nicolò Borsellino ◽  
Giuseppe Cannata ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Metastatic Squamous Cell Carcinoma ◽  
Line Chemotherapy

Prognostic role of inflammatory index in head and neck squamous-cell carcinoma patients in first line chemotherapy.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e18054-e18054
Author(s):  
Valentina Fausti ◽  
Federica Recine ◽  
Flavia Foca ◽  
Sebastiano Calpona ◽  
Davide Bruschi ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Prognostic Role ◽  
First Line ◽  
Inflammatory Index ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document